Results 111 to 120 of about 49,940 (198)

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page 1318-1331, August 2026.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta, Julia Steriopoulos, Vasiliki Economopoulos, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

Prescription Pattern and Safety of Biologics in Autoimmune Rheumatologic Diseases in Tertiary Care Hospital of Bihar. [PDF]

Clin Med Insights Arthritis Musculoskelet Disord
Shakur AA, Kumar R, Ranjan RK, Hameed S, Mohan L.   +4 more
europepmc   +1 more source

Vancomycin-induced linear IgA bullous dermatosis mimicking Stevens-Johnson syndrome/toxic epidermal necrolysis treated with etanercept. [PDF]

JAAD Case Rep
Alanazi R, Aldahash R, Alanazi SK, Almasoud SH, Alumair NA, Alghamdi W, Alhumidi A.   +6 more
europepmc   +1 more source

Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD). [PDF]

Open Access Rheumatol
Almoallim HM, Bahlas SM, Bawazir Y, Hussein AH, Attia GM, Manasfi H, Bafadhl ZA, Asiri AM, Ali AR, Alomair MM, Alsharaif MM, Almalki HH, Siddiqui MI, Alhazmi AS, Attar SM.   +14 more
europepmc   +1 more source

Effects of sialylated oligosaccharides on the N- and O-glycosylation of etanercept in recombinant CHO cells. [PDF]

Appl Microbiol Biotechnol
Kim TH, Lee HM, Ryu SH, Kim HS, Koo SJ, Kang MJ, You J, Kim YG.   +7 more
europepmc   +1 more source

Biological Therapy for Moderate-to-Severe Psoriasis: A 5-Year Analysis of Patients from Lithuania. [PDF]

Medicina (Kaunas)
Indrisiunaite E, Jonaityte IR, Karmaziene T, Raudonis T.   +3 more
europepmc   +1 more source

Computational modeling-directed combination treatment with etanercept and mifepristone mitigates neuroinflammation in a mouse model of Gulf War Illness. [PDF]

PLoS One
Kelly KA, Felton CM, Billig BK, Yilmaz AA, O'Callaghan JP, Craddock TJA, Broderick G, Klimas N, Michalovicz LT.   +8 more
europepmc   +1 more source

Correction: Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis. [PDF]

BMC Pediatr
Ge L, Gao Y, Chen X, Guo J, Zhang D, Yang Y.   +5 more
europepmc   +1 more source

Anti-Inflammatory and Synaptic Protective Effects of TNF-α Inactivation in the MDX Mouse Model. [PDF]

Curr Issues Mol Biol
Bonani AO, Matheus V, Tomiyama ALMR, de Oliveira ALR.   +3 more
europepmc   +1 more source

Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan. [PDF]

J Pharm Policy Pract
Mamiya H, Fukasawa T, Kawakami K.
europepmc   +1 more source